Patents by Inventor Joyce Sutcliffe

Joyce Sutcliffe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210369669
    Abstract: The present disclosure relates to pharmaceutical compositions, pharmaceutical combinations and methods of treatment including zileuton, edaravone and atorvastatin compounds combined with nephrotoxicity-inducing antibiotic or anticancer drugs for treating bacterial infections and cancers.
    Type: Application
    Filed: October 18, 2019
    Publication date: December 2, 2021
    Applicant: SystaMedic Inc.
    Inventors: Anton Franz Joseph FLIRI, Palaniyandi MANIVASAKAM, Joyce SUTCLIFFE
  • Publication number: 20190000761
    Abstract: The present invention relates to methods for treating and preventing acne or P. acnes infection in a subject comprising topically administering to the subject in need thereof an anti-acne nanoemulsion composition, comprising CPC or BKC as a cationic agent.
    Type: Application
    Filed: July 29, 2016
    Publication date: January 3, 2019
    Applicant: NanoBio Corporation
    Inventors: Joyce SUTCLIFFE, Susan CIOTTI, James R. BAKER
  • Patent number: 9371283
    Abstract: The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: June 21, 2016
    Assignee: Tetraphase Pharmaceuticals, Inc.
    Inventors: Xiao-Yi Xiao, Roger Clark, Diana Hunt, Magnus Rönn, Louis Plamondon, Minsheng He, Joyce Sutcliffe, Trudy Grossman
  • Publication number: 20110269714
    Abstract: The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.
    Type: Application
    Filed: March 30, 2011
    Publication date: November 3, 2011
    Applicant: Tetraphase Pharmaceuticals, Inc.
    Inventors: Xiao-Yi Xiao, Roger Clark, Diana Hunt, Magnus Rönn, Louis Plamondon, Minsheng He, Joyce Sutcliffe, Trudy Grossman
  • Publication number: 20080119419
    Abstract: The invention provides a family of bifunctional heterocyclic compounds useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. The invention also provides methods of making the bifunctional heterocyclic compounds, and methods of using such compounds as anti-infective, anti-proliferative agents, anti-inflammatory, and/or prokinetic agents.
    Type: Application
    Filed: December 21, 2007
    Publication date: May 22, 2008
    Inventors: Deping Wang, Joyce Sutcliffe, Adegboyega Oyelere, Timothy McConnell, Joseph Ippolito, John Abelson, Dane Springer, Joseph Salvino, Joel Goldberg, Rongliang Lou, Jay Farmer, Erin Duffy, Ashoke Bhattacharjee
  • Publication number: 20080045585
    Abstract: The present invention provides macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents.
    Type: Application
    Filed: February 25, 2005
    Publication date: February 21, 2008
    Inventors: Jay Farmer, Ashoke Bhattacharjee, Yi Chen, Joel Goldberg, Joseph Ippolito, Zoltan Kanyo, Rongliang Lou, Adegboyega Oyelere, Edward Sherer, Joyce Sutcliffe, Deping Wang, Yusheng Wu, Yanming Du
  • Publication number: 20070249577
    Abstract: The present invention relates to methods for reducing the risk of infection due to surgical or invasive medical procedures. The present invention also relates to methods for preventing infection due to surgical or invasive medical procedures.
    Type: Application
    Filed: April 4, 2007
    Publication date: October 25, 2007
    Inventors: Scott Hopkins, Robert Kessler, Albert Collinson, Joyce Sutcliffe
  • Publication number: 20070238719
    Abstract: The present invention relates to methods for reducing the risk of infection due to surgical or invasive medical procedures. The present invention also relates to methods for preventing infection due to surgical or invasive medical procedures.
    Type: Application
    Filed: May 10, 2006
    Publication date: October 11, 2007
    Inventors: Scott Hopkins, Robert Kessler, Albert Collinson, Joyce Sutcliffe
  • Publication number: 20060264385
    Abstract: The invention provides a family of bifunctional heterocyclic compounds useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. The invention also provides methods of making the bifunctional heterocyclic compounds, and methods of using such compounds as anti-infective, anti-proliferative agents, anti-inflammatory, and/or prokinetic agents.
    Type: Application
    Filed: February 21, 2006
    Publication date: November 23, 2006
    Inventors: Deping Wang, Joyce Sutcliffe, Adegboyega Oyelere, Timothy McConnell, Joseph Ippolito, John Abelson, Dane Springer, Joseph Salvino, Rongliang Lou, Joel Goldberg, Jay Farmer, Erin Duffy, Ashoke Bhattacharjee
  • Publication number: 20050272681
    Abstract: The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.
    Type: Application
    Filed: February 25, 2005
    Publication date: December 8, 2005
    Applicants: Yale University, Rib-X Pharmaceuticals
    Inventors: Thomas Steitz, Peter Moore, Joyce Sutcliffe, Adegboyega Oyelere, Joseph Ippolito
  • Publication number: 20050197334
    Abstract: The invention provides a family of bifunctional heterocyclic compounds useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. The invention also provides methods of making the bifunctional heterocyclic compounds, and methods of using such compounds as anti-infective, anti-proliferative agents, anti-inflammatory, and/or prokinetic agents.
    Type: Application
    Filed: September 25, 2003
    Publication date: September 8, 2005
    Inventors: Deping Wang, Joyce Sutcliffe, Adegboyega Oyelere, Timothy McConnell, Joseph Ippolito, John Abelson, Dane M. Springer, Joseph M. Salvino, Rongliang Lou, Joel A. Goldberg, Jay J. Farmer, Erin M. Duffy, Ashoke Bhattacharjee
  • Publication number: 20050036997
    Abstract: The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.
    Type: Application
    Filed: August 2, 2002
    Publication date: February 17, 2005
    Applicants: Yale University, Rib-X Pharmaceuticals, Inc.
    Inventors: Thomas Steitz, Peter Moore, Joyce Sutcliffe, Adegboyega Oyelere, Joseph Ippolito
  • Patent number: 5985912
    Abstract: Compounds of the formula The compounds are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: November 16, 1999
    Assignee: Pfizer Inc.
    Inventors: Bingwei Yang, Joyce Sutcliffe, Chris J. Dutton
  • Patent number: 5624951
    Abstract: A compound of formula V: ##STR1## wherein all the R's groups are as defined in the specification, is useful in the treatment of bacterial infections.
    Type: Grant
    Filed: March 1, 1995
    Date of Patent: April 29, 1997
    Assignee: Pfizer Inc.
    Inventors: Bingwei Yang, Joyce Sutcliffe, Chris J. Dutton